CHARACTERISTICS OF TREC AND KREC COPY NUMBERS IN PEDIATRIC PATIENTS WITH INBORN ERRORS OF IMMUNITY

Thị Thanh Hiệp Nguyễn1, , Thị Mai Anh Nguyễn1, Nguyễn Liên Anh Phan1,2
1 Đại học Y Dược Thành Phố Hồ Chí Minh
2 Bệnh viện Nhi Đồng 1

Main Article Content

Abstract

Background: Quantification of T-cell receptor excision circles (TREC) and kappa-deleting recombination excision circles (KREC) reflects newly generated T and B lymphopoiesis in the thymus and bone marrow and is commonly applied in newborn screening for severe immunodeficiency. However, data regarding the value of these markers in pediatric patients with Inborn Errors of Immunity (IEI) in Vietnam remain limited, particularly in relation to circulating mature lymphocyte subsets in peripheral blood.


Objective: To describe TREC and KREC levels and their association with peripheral blood lymphocyte subsets (CD3, CD4, CD8, CD19) in pediatric patients with IEI.


Methods: A cross-sectional descriptive study was conducted in 24 pediatric patients diagnosed with IEI who were treated and followed at the Hematology-Dengue Department, Children’s Hospital 1, from June 2025 to February 2026.


Results: The male-to-female ratio was 1:1, and the 1-6 year age group accounted for the highest proportion. Infection was the most common clinical manifestation (58.3%). IEI categories directly affecting lymphocyte development and function (groups 1-3 according to the 2024 IUIS classification) accounted for 58.3% of cases. Reduced TREC levels were observed in 92.8% of patients in groups 1-3 and in 80% of patients in the remaining groups. Reduced KREC levels were identified in 50% of patients in groups 1-3 and in 70% of patients in other groups. In most cases, TREC and KREC levels were concordant with peripheral lymphocyte subsets (CD3, CD4, CD8, CD19), showing either simultaneous reduction or normal values. However, 37.5% of cases demonstrated reduced TREC and/or KREC despite lymphocyte counts remaining within age-adjusted reference ranges, suggesting the potential for early detection of impaired lymphopoiesis before a marked decline in circulating lymphocytes. This discordance was also observed in some patients with autoimmune manifestations who belonged to IEI groups not directly associated with classical lymphocyte developmental defects.


Conclusion: TREC and KREC reflect abnormalities in lymphocyte generation in pediatric IEI, including cases outside classical lymphopoietic disorders. Reduced TREC and/or KREC may occur even when peripheral blood lymphocyte counts remain within age-adjusted reference ranges and were also observed in some patients with autoimmune manifestations. The combined assessment of TREC, KREC, and lymphocyte subsets may support evaluation of lymphopoietic impairment in clinical practice and warrants further investigation regarding the role of these markers.

Article Details

References

1. Abolhassani H, Sharifi L, Yazdani R, et al. Global systematic review of primary immunodeficiency registries. Expert Rev Clin Immunol. 2020;16(7):717-732.
2. Itakura T, Sasaki H, Hosoya T, et al. The role of TRECs/KRECs as immune indicators that reflect immunophenotypes and predict the risk of infection in systemic autoimmune diseases. Immunological Medicine. 2025;48(3):233-244.
3. Kwok JSY, Cheung SKF, Ho JCY, et al. Establishing simultaneous T cell receptor excision circles (TREC) and K-deleting recombination excision circles (KREC) quantification assays and laboratory reference intervals in healthy individuals of different age groups in Hong Kong. Front Immunol. 2020;11:1411.
4. Lee WI HJ, Huang JL, Lin SJ, et al. Applying T-cell receptor excision circles and immunoglobulin κ-deleting recombination excision circles to patients with primary immunodeficiency diseases. Annals of Medicine. 2014;46:555-565.
5. Serana F, Chiarini M, Zanotti C, et al. Use of V(D)J recombination excision circles to identify T- and B-cell defects and to monitor the treatment in primary and acquired immunodeficiencies. J Transl Med. 2013;11:119.
6. Thalhammer J, Kindle G, Nieters A, et al. Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations. J Allergy Clin Immunol. 2021;148(5):1332-1341.
7. Wagner U, Baerwald C, Rossol M. Deficient Thymic Output in Rheumatoid Arthritis Despite Abundance of Prethymic Progenitors. Arthritis Rheum. 2013;65(10):2567-2572.
8. Wang R, Lan C, Benlagha K, et al. The interaction of innate immune and adaptive immune system. MedComm. 2024:5:e714